Clover Biopharmaceuticals, Ltd.

HKEX:2197.HK

0.22 (HKD) • At close September 19, 2024
Bedrijfsnaam Clover Biopharmaceuticals, Ltd.
Symbool 2197.HK
Munteenheid HKD
Prijs 0.218
Beurswaarde 282,756,650
Dividendpercentage 0%
52-weken bereik 0.201 - 0.9
Industrie Biotechnology
Sector Healthcare
CEO Mr. Joshua G. Liang
Website https://www.cloverbiopharma.com

An error occurred while fetching data.

Over Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd., a biotechnology company, engages in the research, development, and commercialization of novel vaccines and biologic therapeutic candidates for infectious diseases, and cancer and autoimmune diseases. It is developing SCB-2019 (CpG 1018/Alum), a COVID-19 vaccine candidate that is in Phase II/III clinical trial; SCB-313, a trimeric fusion protein

Vergelijkbare Aandelen

China Shineway Pharmaceutical Group Limited logo

China Shineway Pharmaceutical Group Limited

2877.HK

7.86 HKD

C-MER Eye Care Holdings Limited logo

C-MER Eye Care Holdings Limited

3309.HK

2.11 HKD

Venus Medtech (Hangzhou) Inc. logo

Venus Medtech (Hangzhou) Inc.

2500.HK

5.62 HKD

MicroPort CardioFlow Medtech Corporation logo

MicroPort CardioFlow Medtech Corporation

2160.HK

0.68 HKD

Frontage Holdings Corporation logo

Frontage Holdings Corporation

1521.HK

0.61 HKD

China Resources Medical Holdings Company Limited logo

China Resources Medical Holdings Company Limited

1515.HK

3.47 HKD

AK Medical Holdings Limited logo

AK Medical Holdings Limited

1789.HK

4.15 HKD

Viva Biotech Holdings logo

Viva Biotech Holdings

1873.HK

0.61 HKD

Antengene Corporation Limited logo

Antengene Corporation Limited

6996.HK

0.54 HKD

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. logo

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

1558.HK

8.19 HKD

Financiële Gegevens

Cijfers zijn in miljoenen (HKD)

Cijfers zijn in miljoenen (HKD)